The risk of venous thrombosis in individuals with a history of superficial vein thrombosis and acquired venous thrombotic risk factors

Blood

Volumn 122, Issue 26, 2013, Pages 4264-4269

  Roach, Rachel E J ^a   Lijfering, Willem M ^a   Van Hylckama Vlieg, Astrid ^a   Helmerhorst, Frans M ^a   Rosendaal, Frits R ^a   Cannegieter, Suzanne C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTRACEPTION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; HORMONAL THERAPY; HOSPITALIZATION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; ORAL CONTRACEPTION; PERIPHERAL VEIN; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; RISK FACTOR; SMOKING; SUPERFICIAL VEIN THROMBOSIS; THROMBOSIS; VEIN THROMBOSIS; YOUNG ADULT;

EID: 84891059868     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-07-518159     Document Type: Article

References (13)

1. Di Nisio M, Wichers IM, Middeldorp S. Treatment for superficial thrombophlebitis of the leg. Cochrane Database Syst Rev. 2013; (4): CD004982.
2. Decousus H, Epinat M, Guillot K, Quenet S, Boissier C, Tardy B. Superficial vein thrombosis: risk factors, diagnosis, and treatment. Curr Opin Pulm Med. 2003;9 (5):393-397.
3. Decousus H, Quéré I, Presles E, et al; POST (Prospective Observational Superficial Thrombophlebitis) Study Group. Superficial venous thrombosis and venous thromboembolism: a large, prospective epidemiologic study. Ann Intern Med. 2010; 152 (4):218-224.
4. Kitchens CS. How I treat superficial venous thrombosis. Blood. 2011;117 (1):39-44.
5. van Langevelde K, Lijfering WM, Rosendaal FR, Cannegieter SC. Increased risk of venous thrombosis in persons with clinically diagnosed superficial vein thrombosis: results from the MEGA study. Blood. 2011;118 (15):4239-4241.
6. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ III. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med. 2000;160 (6):809-815.
7. Martinelli I, Cattaneo M, Taioli E, De Stefano V, Chiusolo P, Mannucci PM. Genetic risk factors for superficial vein thrombosis. Thromb Haemost. 1999;82 (4):1215-1217.
8. Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA. 2005;293 (6): 715-722.
9. van Langevelde K, Flinterman LE, van Hylckama Vlieg A, Rosendaal FR, Cannegieter SC. Broadening the factor V Leiden paradox: pulmonary embolism and deep-vein thrombosis as 2 sides of the spectrum. Blood. 2012;120 (5): 933-946.
10. Binder B, Lackner HK, Salmhofer W, Kroemer S, Custovic J, Hofmann-Wellenhof R. Association between superficial vein thrombosis and deep vein thrombosis of the lower extremities. Arch Dermatol. 2009;145 (7):753-757.
11. WHO Expert Group. Medical Eligibility Criteria for Contraceptive Use. 4th ed. 2009. Available at: http://whqlibdoc.who.int/publications/2010/ 9789241563888-eng.pdf. Accessed July 1, 2013.
12. Leizorovicz A, Becker F, Buchmüller A, Quér ́e I, Prandoni P, Decousus H; CALISTO Study Group. Clinical relevance of symptomatic superficial-vein thrombosis extension: lessons from the CALISTO study. Blood. 2013;122 (10): 1724-1729.
13. van Weert H, Dolan G, Wichers I, de Vries C, ter Riet G, Buller H. Spontaneous superficial venous thrombophlebitis: does it increase risk for thromboembolism? A historic follow-up study in primary care. J Fam Pract. 2006;55 (1): 52-57.